Mazyar Shadman, MD, MPH
Dr. Shadman is an Associate Professor of Hematology & Oncology and the Medical Director of Cellular Immunotherapy at the Fred Hutch Cancer Center / University of Washington. He also serves as the Innovators Network Endowed Chair.
Disclosures: Dr. Shadman reports consulting or serving on advisory boards, steering committees, or data safety monitoring committees for AbbVie, Genentech, AstraZeneca, Genmab, Janssen, Beigene, BNS, Kite Pharma, Eli Lilly, Fate Therapeutics, Nurix, and Merck. He also reports research funding tied to Mustang Bio, Genentech, AbbVie, BeiGene, AstraZeneca, Genmab, Morphosys/Incyte, and Vincerx and Bristol Myers Squibb (spouse).
